Zimmer Biomet Announces New Data Supporting Clinical Benefits of mymobility® with Apple Watch® at AAOS 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Zimmer Biomet to Unveil New Clinical Data and Portfolio of Innovative Technologies at AAOS 2021 Annual Meeting prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
WARSAW, Ind., April 20, 2021 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA
® Partial Knee System for robotically-assisted partial knee replacement surgeries. The ROSA Partial Knee System is the newest addition to ROSA Robotics, Zimmer Biomet s multiple application robotics platform which includes the ROSA Knee System for total knee replacement surgery and ROSA ONE
® for neurosurgical and spine procedures. The Rosa Partial Knee System is also now a component of
ZBEdge, bringing another robotic solution to Zimmer Biomet s suite of integrated digital and robotic technologies.